ArticleEuropean archives of psychiatry and clinical neuroscience2026
Clinical outcomes in first-episode psychoses: does age at admission matter?
Article in European archives of psychiatry and clinical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim of this retrospective study was to identify differences in terms of clinical presentation and outcomes of First Episode Psychosis (FEP) patients admitted to the "Parma Early Psychosis program" (Pr-EP), which accepts FEP up to age 54, considering age at admission.
methodsIndividuals aged 18-54 years, with an affective or non-affective FEP diagnosis, were compared for sociodemographic and clinical characteristics both at baseline and after 1 and 2 years based on sex (M vs F) and age (≤35 vs 36+) at admission. Regression analysis and time by age model was used to identify predictors of clinical recovery and overall clinical severity measured by the Health of the Nation Outcome Scale - Mental Health Clustering Tool (HoNOS-MHCT).
resultsA total of 447 individuals were included, most were males (65.1%). At baseline, the 36+ group had higher illness severity (mean HoNOS total score 26 vs 22.4, p=0.002), particularly on social functioning. In the 2 year follow up, those 36+ presented more severe symptoms and more functional disabilities vs those ≤35s. At both follow-ups, 36+ attended CBT sessions less frequently than those ≤35, whilst attending more CBT sessions was a positive predictor of clinical recovery. At 2 years but not at 1 year follow up, being prescribed a higher antipsychotic dose was a negative predictor of clinical recovery (OR 0.89, CI 0.80-0.97, p=0.018), as being in the 36+ group (OR 0.44, CI 0.20-0.92, p=0.035).
conclusionsThis study confirmed that FEP patients have different characteristics in terms of their pathways to care and clinical presentation based on their sex and age at admission to services, which might affect outcomes and requires targeted intervention.
Indexed as
Identifiers
42853269What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.